Dr. Kevin Tracey, CEO of the Feinstein Institutes for Medical Research, discusses the need for developing more treatments for COVID-19 and other viruses. Bloomberg Opinion Politics Columnist Jonathan Bernstein explains why getting an infrastructure deal wasn't simple. Chainalysis CEO Michael Gronager talks about raising $100 million in funding for the blockchain analysis company. And we Drive to the Close with Christian Munafo, CIO at Liberty Street Advisors. 

Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.

Dr. Kevin Tracey, CEO of the Feinstein Institutes for Medical Research, discusses the need for developing more treatments for COVID-19 and other viruses. Bloomberg Opinion Politics Columnist Jonathan Bernstein explains why getting an infrastructure deal wasn't simple. Chainalysis CEO Michael Gronager talks about raising $100 million in funding for the blockchain analysis company. And we Drive to the Close with Christian Munafo, CIO at Liberty Street Advisors. Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.

Listen for reporting from the magazine that helps global leaders stay ahead. Hosts Carol Massar and Tim Stenovec cover the changing world of money, power and technology. You can watch and listen to Businessweek LIVE on YouTube, weekdays from 2PM to 5PM ET: http://bit.ly/3vTiACF. 

Listen for reporting from the magazine that helps global leaders stay ahead. Hosts Carol Massar and Tim Stenovec cover the changing world of money, power and technology.&nbsp;You can watch and listen to Businessweek LIVE on YouTube, weekdays from 2PM to 5PM ET:&nbsp;<a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.&nbsp;

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors.

Bloomberg Businessweek

The Importance of Investing in Medical Research

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/cc90b462-4fa8-40f3-a4e8-ae2b002f8c23/transcript

Blackstone Life Sciences, which has some $17 billion in assets under management, typically invests in late-stage medicines invented by biotech and pharmaceutical companies in exchange for a royalty on future sales. In 2024, for example, the firm invested as much as $750 million in financing for Moderna’s flu vaccine development.

But Blackstone also wants to own a stake in some companies that it backs. 
In late March, Blackstone closed its latest life-sciences fund with $6.3 billion of commitments, the firm’s biggest haul for backing clinical trials of medicines and technologies. 

Dr. Jenny Rooke is Founder and Managing Director of Genoa Ventures. She discusses the cross between tech and health with Carol Massar and Tim Stenovec.

Blackstone Life Sciences, which has some $17 billion in assets under management, typically invests in late-stage medicines invented by biotech and pharmaceutical companies in exchange for a royalty on future sales. In 2024, for example, the firm invested as much as $750 million in financing for Moderna&rsquo;s flu vaccine development. But Blackstone also wants to own a stake in some companies that it backs. In late March, Blackstone closed its latest life-sciences fund with $6.3 billion of commitments, the firm&rsquo;s biggest haul for backing clinical trials of medicines and technologies.&nbsp; Dr. Jenny Rooke is Founder and Managing Director of Genoa Ventures. She discusses the cross between tech and health with Carol Massar and Tim Stenovec.

Investing in Life Sciences

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/bff6d8f0-2d30-433d-9752-b444015e5d1a/transcript

Featuring some of our favorite conversations of the week from our daily radio show “Bloomberg Businessweek Daily.”  

Hosted by Carol Massar and Tim Stenovec Hear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 92.9 FM Boston, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 121, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio. You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News.  

Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno and @BW

Featuring some of our favorite conversations of the week from our daily radio show &ldquo;Bloomberg Businessweek Daily.&rdquo; &nbsp; Hosted by Carol Massar and Tim Stenovec Hear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 92.9 FM Boston, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 121, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio. You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News. &nbsp; Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno and @BW

Bloomberg Businessweek Weekend: May 8th, 2026

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/f8ddb3e3-a89d-4c7f-87bd-b44401669306/transcript

The people, companies and trends shaping the global economy.

Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.

Bloomberg Businessweek visited Three Mile Island and went inside the training facility preparing for the the plant to come back online as soon as mid-2027. Thanks to a long-term agreement signed by Microsoft Corp. and Constellation Energy Corp. in September 2024, the energy from the plant will power chatbots and other artificial intelligence applications. 

All this under a new and baggage-free name: the Crane Clean Energy Center. The agreement commits Microsoft to buying all the electricity produced by the site’s remaining functional 835-megawatt reactor for 20 years.


Today's show features:
Will Wade, Bloomberg Energy Reporter on how Microsoft's vast power demands are bringing together two transformative—and risky—technologies
Christel Rendu de Lint, co-CEO at Vontobel
Daniel Barcelo, Chairman and CEO at T1 Energy on state of energy industry
Michael Gross, SLR Capital Partners Co-Founder and James Crombie, Bloomberg Senior Editor for Credit on state of Private Credit
Meenakshi Lala, CEO at UrbanStems

The people, companies and trends shaping the global economy.
Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.
Bloomberg Businessweek visited Three Mile Island and went inside the training facility preparing for the the plant to come back online as soon as mid-2027. Thanks to a long-term agreement signed by Microsoft Corp. and Constellation Energy Corp. in September 2024, the energy from the plant will power chatbots and other artificial intelligence applications.&nbsp;
All this under a new and baggage-free name: the Crane Clean Energy Center. The agreement commits Microsoft to buying all the electricity produced by the site&rsquo;s remaining functional 835-megawatt reactor for 20 years.
 Today's show features:
<ul>
<li>Will Wade, Bloomberg Energy Reporter on how Microsoft's vast power demands are bringing together two transformative&mdash;and risky&mdash;technologies</li>
<li>Christel Rendu de Lint, co-CEO at Vontobel</li>
<li>Daniel Barcelo, Chairman and CEO at T1 Energy on state of energy industry</li>
<li>Michael Gross, SLR Capital Partners Co-Founder and James Crombie, Bloomberg Senior Editor for Credit on state of Private Credit</li>
<li>Meenakshi Lala, CEO at UrbanStems</li>
</ul>

Inside the AI Revival of the Infamous Three Mile Island Nuclear Plant

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/5ada08c1-b2bc-449c-ad17-b444015b29db/transcript

The Importance of Investing in Medical Research

In 1 playlist(s)

Bloomberg Businessweek

Social links

Follow podcast

Recent clips